Clinical Trial Update: Efficacy and Safety of AQX-1125 in Subjects With Chronic Prostatitis/Chronic Pelvic Pain Syndrome [Phase 2]

View source ↗

Summary

Phase 2 trial examining AQX-1125 for chronic prostatitis and chronic pelvic pain syndrome was terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pelvic Pain Syndrome
• Prostatitis

Drugs mentioned

• AQX-1125

Snippet

Sponsor: Aquinox Pharmaceuticals (Canada) Inc. | Conditions: Chronic Prostatitis, Chronic Pelvic Pain Syndrome | Phase 2 | Status: TERMINATED | Results posted: 2019-01-09